phorbolol myristate acetate has been researched along with bisdemethoxycurcumin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiou, SY; Ho, CT; Kou, MC; Wang, L; Weng, CY; Wu, MJ | 1 |
Azzi, A; Dolnikowski, GG; Kim, SH; Meydani, M; Miyazawa, T; Nakagawa, K; Thomas, MJ; Zingg, JM | 1 |
Kang, OH; Kim, SA; Kong, R; Kwon, DY; Seo, YS; Shin, DW; Zhou, T | 1 |
3 other study(ies) available for phorbolol myristate acetate and bisdemethoxycurcumin
Article | Year |
---|---|
Curcuminoids distinctly exhibit antioxidant activities and regulate expression of scavenger receptors and heme oxygenase-1.
Topics: Antioxidants; Biomarkers; CD36 Antigens; Cell Differentiation; Cell Line, Tumor; Copper; Curcumin; Diarylheptanoids; Foam Cells; Gene Expression Regulation; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Lipid Peroxidation; Lipoproteins, LDL; Monocytes; Scavenger Receptors, Class A; Scavenger Receptors, Class E; Tetradecanoylphorbol Acetate; Thiobarbituric Acid Reactive Substances; Up-Regulation | 2013 |
Differential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulation.
Topics: Biological Transport; Carcinogens; Cell Differentiation; Cell Line; Chromatography, High Pressure Liquid; Curcumin; Diarylheptanoids; Glucuronides; Humans; Kinetics; Lipid Metabolism; Macrophages; Monocytes; Sulfates; Tandem Mass Spectrometry; Tetradecanoylphorbol Acetate | 2014 |
MAPKs and NF‑κB pathway inhibitory effect of bisdemethoxycurcumin on phorbol‑12‑myristate‑13‑acetate and A23187‑induced inflammation in human mast cells.
Topics: Calcimycin; Cell Line; Curcumin; Diarylheptanoids; Gene Expression Regulation; Humans; Inflammation; Mast Cells; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor RelA | 2018 |